NOW ENROLLING: CANaspire, Aspa’s investigational gene therapy trial for patients with Canavan disease.
Families can call 1-833-764-2267 (toll-free) or 1-617-861-4617 or email CANaspire@aspatx.com to reach a trial representative.

Aspa recently shared encouraging preliminary findings from its ongoing intravenous (IV) AAV9 gene therapy trial. To learn more, click here.